Advances in role and mechanism of corilagin in hepatitis,liver fibrosis and hepatic carcinoma
10.3969/j.issn.1000-484X.2024.07.034
- VernacularTitle:柯里拉京在肝炎、肝纤维化和肝癌中的作用及机制研究进展
- Author:
Xinyu LIU
1
;
Xiaorui SHI
;
Hui ZHANG
;
Fenglian YAN
Author Information
1. 济宁医学院基础医学院免疫学与分子医学研究所,济宁 272067
- Keywords:
Liver disease;
Corilagin;
Hepatitis;
Liver fibrosis;
Hepatic carcinoma;
Mechanism
- From:
Chinese Journal of Immunology
2024;40(7):1548-1552
- CountryChina
- Language:Chinese
-
Abstract:
Corilagin is one of major bioactive compounds in many Chinese medical plants,which has been demonstrated to exhibit multiple pharmacological activities.Hepatoprotective effects of corilagin have been reported in some liver diseases,such as hepatitis,liver fibrosis and hepatic carcinoma.Therefore,corilagin has shown broad prospects in treatment of liver diseases.However,problems exposed in application process prompted researchers to further explore potential role of corilagin.Research progress of the role and mechanism of corilagin in hepatitis,liver fibrosis and hepatic carcinoma are summarized to provide reference for subsequent studies.
